T Cell News and Research

Latest T Cell News and Research

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

23 Mar 2022
Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response

22 Mar 2022
Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

21 Mar 2022
Sex-specific differences in T-cell responses to COVID-19

Sex-specific differences in T-cell responses to COVID-19

20 Mar 2022
Response to COVID-19 boosters in seronegative multiple sclerosis patients

Response to COVID-19 boosters in seronegative multiple sclerosis patients

20 Mar 2022
Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

19 Mar 2022
Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

17 Mar 2022
BNT162b2 booster vaccination induces robust humoral and cellular immune responses

BNT162b2 booster vaccination induces robust humoral and cellular immune responses

17 Mar 2022
Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

Researchers evaluate predictors for mortality in hospitalized COVID-19 patients

17 Mar 2022
Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

17 Mar 2022
The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

17 Mar 2022
Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

15 Mar 2022
Immune cells could help predict the prognosis of patients with ALS

Immune cells could help predict the prognosis of patients with ALS

15 Mar 2022
Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

10 Mar 2022
SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

7 Mar 2022
Diabetes and the mTOR pathway in COVID-19 patients

Diabetes and the mTOR pathway in COVID-19 patients

6 Mar 2022
CD4 T-cell immunity active six months into COVID-19 convalescence

CD4 T-cell immunity active six months into COVID-19 convalescence

6 Mar 2022
Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

6 Mar 2022
T-cell cytokine and fatty acid work together to trigger a type of cell death

T-cell cytokine and fatty acid work together to trigger a type of cell death

4 Mar 2022
Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

3 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback